According to Ireland’s foreign direct investment (FDI) agency, IDA Ireland, the facility at Clonshaugh spans two sites within the IDA Business Park and provides supply chain, manufacturing and engineering services for AbbVie’s global network.
Following the company’s recent expansion in Ireland, the site is now home to about 400 employees.
“Our new AbbVie North Dublin facility will be a key node in AbbVie’s global operations network, serving as a European hub bringing together our Dublin-based supply chain, engineering, quality assurance and manufacturing teams for the first time,” said Azita Saleki-Gerhardt, AbbVie’s executive vice-president and chief operations officer.
News of AbbVie’s North Dublin expansion comes after the company invested €60m in the southern Irish city of Cork in 2022, bringing its total investment in the country to more than €430m.
Ireland has become an increasingly attractive FDI destination following the UK’s decision to leave the EU, with Dublin turning itself into a global hub for many financial companies looking for an English-speaking branch with ties to the EU.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData
The pharma sector, in particular, has seen six FDI projects from major players in Ireland, including Merck and AbbVie, since the beginning of the year, according to GlobalData’s FDI Projects database.
Michael Lohan, CEO of IDA Ireland, welcomed AbbVie’s recent expansion, saying: “The opening of this new European services hub is a wonderful addition to the six locations across Ireland that AbbVie currently operates in.
“This is a continued endorsement of Ireland as a strategic location for biopharmaceutical investment and one we are very proud of. This new hub will place Ireland at the centre of the European supply chain. Since AbbVie arrived in Ireland in 1974, the country has continued to grow as a global hub for life sciences and be at the forefront of innovation. IDA is delighted to be a long-standing partner with AbbVie now and into the future.”